{"id":"https://openalex.org/W2565327235","doi":"https://doi.org/10.3906/sag-1511-184","title":"The combined effects of proteasome inhibitor bortezomib with topoisomerase I and II inhibitors on topoisomerase enzymes","display_name":"The combined effects of proteasome inhibitor bortezomib with topoisomerase I and II inhibitors on topoisomerase enzymes","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2565327235","doi":"https://doi.org/10.3906/sag-1511-184","mag":"2565327235","pmid":"https://pubmed.ncbi.nlm.nih.gov/28081343"},"language":"en","primary_location":{"id":"doi:10.3906/sag-1511-184","doi":"https://doi.org/10.3906/sag-1511-184","is_oa":false,"landing_page_url":"https://doi.org/10.3906/sag-1511-184","pdf_url":null,"source":{"id":"https://openalex.org/S68332911","display_name":"TURKISH JOURNAL OF MEDICAL SCIENCES","issn_l":"1300-0144","issn":["1300-0144","1303-6165"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","ddh","doaj","dongbi-b","medline","norway-1","poland-40","russia-white-list-1","tr-dizin"],"host_organization":"https://openalex.org/P4310318422","host_organization_name":"Scientific and Technological Research Council of Turkey (TUBITAK)","host_organization_lineage":["https://openalex.org/P4310318422"],"host_organization_lineage_names":["Scientific and Technological Research Council of Turkey (TUBITAK)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"TURKISH JOURNAL OF MEDICAL SCIENCES","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022448558","display_name":"Emine \u00d6ks\u00fczo\u011flu","orcid":"https://orcid.org/0000-0003-4106-1056","observed_orcids":["https://orcid.org/0000-0003-4106-1056"]},"institutions":[{"id":"https://openalex.org/I121596126","display_name":"Aksaray University","ror":"https://ror.org/026db3d50","country_code":"TR","type":"education","lineage":["https://openalex.org/I121596126"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Emine \u00d6KS\u00dcZO\u011eLU","raw_affiliation_strings":["Molecular Biology Division, Department of Biology, Faculty of Science and Letters, Aksaray University, Aksaray, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology Division, Department of Biology, Faculty of Science and Letters, Aksaray University, Aksaray, Turkey","institution_ids":["https://openalex.org/I121596126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003040252","display_name":"\u00c7iydem T\u0131r\u0131no\u011flu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121596126","display_name":"Aksaray University","ror":"https://ror.org/026db3d50","country_code":"TR","type":"education","lineage":["https://openalex.org/I121596126"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"\u00c7iydem TIRINO\u011eLU","raw_affiliation_strings":["Molecular Biology Division, Department of Biology, Faculty of Science and Letters, Aksaray University, Aksaray, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology Division, Department of Biology, Faculty of Science and Letters, Aksaray University, Aksaray, Turkey","institution_ids":["https://openalex.org/I121596126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009827064","display_name":"Bar\u0131\u015f Kerimo\u011flu","orcid":"https://orcid.org/0000-0002-6078-7648","observed_orcids":["https://orcid.org/0000-0002-6078-7648"]},"institutions":[{"id":"https://openalex.org/I121596126","display_name":"Aksaray University","ror":"https://ror.org/026db3d50","country_code":"TR","type":"education","lineage":["https://openalex.org/I121596126"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Bar\u0131\u015f KER\u0130MO\u011eLU","raw_affiliation_strings":["Molecular Biology Division, Department of Biology, Faculty of Science and Letters, Aksaray University, Aksaray, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Biology Division, Department of Biology, Faculty of Science and Letters, Aksaray University, Aksaray, Turkey","institution_ids":["https://openalex.org/I121596126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I121596126"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11556393,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":"6","first_page":"1882","last_page":"1888"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":1.0},{"id":"https://openalex.org/keywords/topoisomerase-i","display_name":"topoisomerase I","score":0.8240000009536743},{"id":"https://openalex.org/keywords/topoisomerase-ii","display_name":"topoisomerase II","score":1.0},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8169999718666077},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5770000219345093},{"id":"https://openalex.org/keywords/dna-topoisomerase-inhibition","display_name":"DNA topoisomerase inhibition","score":0.8600000143051147},{"id":"https://openalex.org/keywords/ic50","display_name":"IC50","score":0.6970000267028809},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7440000176429749},{"id":"https://openalex.org/keywords/anticancer-drug-targets","display_name":"anticancer drug targets","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.9180369973182678},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.876923680305481},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.8554571270942688},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.8416146039962769},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6196353435516357},{"id":"https://openalex.org/C2778616834","wikidata":"https://www.wikidata.org/wiki/Q281044","display_name":"Topoisomerase inhibitor","level":4,"score":0.5763945579528809},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.5500239729881287},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.538433849811554},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.5304082632064819},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.5292351245880127},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.5176675915718079},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.510148823261261},{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.49145829677581787},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29319989681243896},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2453623116016388},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20004746317863464},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1113927960395813},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10550883412361145},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10499659180641174},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.09140515327453613},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08886522054672241},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.08790966868400574}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004264","descriptor_name":"DNA Topoisomerases, Type I","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3906/sag-1511-184","doi":"https://doi.org/10.3906/sag-1511-184","is_oa":false,"landing_page_url":"https://doi.org/10.3906/sag-1511-184","pdf_url":null,"source":{"id":"https://openalex.org/S68332911","display_name":"TURKISH JOURNAL OF MEDICAL SCIENCES","issn_l":"1300-0144","issn":["1300-0144","1303-6165"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","ddh","doaj","dongbi-b","medline","norway-1","poland-40","russia-white-list-1","tr-dizin"],"host_organization":"https://openalex.org/P4310318422","host_organization_name":"Scientific and Technological Research Council of Turkey (TUBITAK)","host_organization_lineage":["https://openalex.org/P4310318422"],"host_organization_lineage_names":["Scientific and Technological Research Council of Turkey (TUBITAK)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"TURKISH JOURNAL OF MEDICAL SCIENCES","raw_type":"journal-article"},{"id":"pmid:28081343","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28081343","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Turkish journal of medical sciences","raw_type":"Journal Article"},{"id":"pmh:oai:dergipark.org.tr:article/576015","doi":null,"is_oa":false,"landing_page_url":"https://dergipark.org.tr/tr/pub/tbtkmedical/issue/45676/576015","pdf_url":null,"source":{"id":"https://openalex.org/S4306401840","display_name":"DergiPark (Istanbul University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67581229","host_organization_name":"Istanbul University","host_organization_lineage":["https://openalex.org/I67581229"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\\n Volume: 46, Issue: 6\\n 1882-1888\\n \\n","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320326157","display_name":"Aksaray \u00dcniversitesi","ror":"https://ror.org/026db3d50"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1495821285","https://openalex.org/W1499356698","https://openalex.org/W1536538430","https://openalex.org/W1654790906","https://openalex.org/W1778682649","https://openalex.org/W1963775903","https://openalex.org/W1965326858","https://openalex.org/W1979591487","https://openalex.org/W1984673904","https://openalex.org/W1984682886","https://openalex.org/W1989789824","https://openalex.org/W2001555736","https://openalex.org/W2003214628","https://openalex.org/W2004148739","https://openalex.org/W2014014132","https://openalex.org/W2018345280","https://openalex.org/W2020812039","https://openalex.org/W2027348595","https://openalex.org/W2063354329","https://openalex.org/W2064185538","https://openalex.org/W2096439168","https://openalex.org/W2099395323","https://openalex.org/W2111047350","https://openalex.org/W2123077018","https://openalex.org/W2132485651","https://openalex.org/W2132600317","https://openalex.org/W2189366730","https://openalex.org/W3022432663","https://openalex.org/W4236530034"],"related_works":["https://openalex.org/W2080348222","https://openalex.org/W1990573114","https://openalex.org/W2227960048","https://openalex.org/W2235523066","https://openalex.org/W1969124374","https://openalex.org/W2010781083","https://openalex.org/W2121454394","https://openalex.org/W2557242254","https://openalex.org/W2069338176","https://openalex.org/W2128336187"],"abstract_inverted_index":{"Background/aim:":[0],"DNA":[1,11],"topoisomerases":[2],"are":[3],"ubiquitous":[4],"enzymes":[5,63,84,100],"that":[6,144,185],"regulate":[7],"conformational":[8],"changes":[9],"in":[10,41,67,90,167,200],"topology":[12],"during":[13],"essential":[14],"cellular":[15,26],"processes,":[16],"and,":[17],"for":[18,192],"this":[19,48,181],"reason,":[20],"have":[21],"been":[22],"characterized":[23],"as":[24],"the":[25,42,52,96,104,125,201],"targets":[27],"of":[28,31,44,55,79,95,180,203],"a":[29,36,112,130,190],"number":[30],"anticancer":[32],"drugs.":[33],"Bortezomib":[34,110],"is":[35,146],"powerful":[37],"proteasome":[38,151],"inhibitor":[39],"used":[40,166,175],"treatment":[43,202],"hematological":[45],"malignancies.":[46],"In":[47,157],"study,":[49],"we":[50],"investigated":[51],"inhibitory":[53,132],"effects":[54],"bortezomib":[56,145,159],"on":[57,98,117,134,150,154],"human":[58],"topoisomerase":[59,83,99,118,135,155],"I":[60,119],"and":[61,66,72,75,171,198],"II":[62,136],"both":[64],"alone":[65],"combination":[68,168,193],"modes":[69],"with":[70,82,169,195],"camptothecin":[71,170],"etoposide.":[73],"Materials":[74],"methods:":[76],"The":[77,178],"interactions":[78],"these":[80,186],"drugs":[81,97],"were":[85,101],"evaluated":[86],"by":[87],"relaxation":[88],"assay":[89],"cell-free":[91],"systems.":[92],"IC50":[93],"values":[94],"calculated":[102],"using":[103],"S":[105],"probit":[106],"analysis":[107],"program.":[108],"Results:":[109],"showed":[111],"very":[113],"weak":[114],"inhibition":[115],"effect":[116,133,164],"(IC50":[120,137],"=":[121,138],"87.11":[122],"mM).":[123,140],"On":[124],"other":[126],"hand,":[127],"it":[128],"had":[129],"strong":[131],"1.41":[139],"Our":[141],"results":[142,179],"indicated":[143],"effective":[147],"not":[148],"only":[149],"but":[152],"also":[153],"II.":[156],"addition,":[158],"possesses":[160],"an":[161],"increased":[162],"synergistic":[163],"when":[165,174],"etoposide":[172,199],"than":[173],"alone.":[176],"Conclusion:":[177],"study":[182],"point":[183],"out":[184],"data":[187],"may":[188],"build":[189],"framework":[191],"studies":[194],"bortezomib,":[196],"camptothecin,":[197],"cancer.":[204]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-01-06T00:00:00"}